Fontris Alts beta The source for Alternative Investment intelligence.

Manager-reported performance evidence.

Calamos Aksia Alternative Credit & Income Fund · This is a first-party manager publication, not an SEC filing.

Total return, fund-stated

Source type
Manager-reported; not from SEC filings
Manager
Calamos/Aksia
Share class
Class I
Valuation date
2024-12-31
Retrieved
2026-08-01T18:49:36.129749+00:00
Document
HTML

Verbatim evidence

<table class="table monthly-returns-table"> <thead> <tr> <th scope="col"> </th> <th scope="col">Jan</th> <th scope="col">Feb</th> <th scope="col">Mar</th> <th scope="col">Apr</th> <th scope="col">May</th> <th scope="col">Jun</th> <th scope="col">Jul</th> <th scope="col">Aug</th> <th scope="col">Sep</th> <th scope="col">Oct</th> <th scope="col">Nov</th> <th scope="col">Dec</th> <th scope="col">Year</th> </tr> </thead> <tbody> <tr> <td><strong>2023</strong></td> <td class="bg-light"></td> <td class="bg-light"></td> <td class="bg-light"></td> <td class="bg-light"></td> <td class="bg-light"></td> <td>0.40*</td> <td>0.70</td> <td>0.89</td> <td>0.59</td> <td>0.77</td> <td>1.67</td> <td>1.12</td> <td>6.31</td> </tr> <tr> <td><strong>2024</strong></td> <td>1.07</td> <td>0.77</td> <td>1.44</td> <td>1.01</td> <td>0.95</td> <td>0.66</td> <td>1.14</td> <td>1.12</td> <td>0.61</td> <td>0.99</td> <td>1.09</td> <td>1.30</td> <td>12.85</td> </tr> <tr> <td><strong>2025</strong></td> <td>0.66</td> <td>0.60</td> <td>0.99</td> <td>0.61</td> <td>1.27</td> <td>0.80</td> <td>0.70</td> <td>0.80</td> <td>0.99</td> <td>0.24</td> <td>0.99</td> <td>0.61</td> <td>9.66</td> </tr> <tr> <td><strong>2026</strong></td> <td>0.66</td> <td>0.47</td> <td>0.66</td> <td>0.66</td> <td>0.38</td> <td>0.38</td> <td></td> <td></td> <td></td> <td></td> <td></td> <td></td> <td>3.25**</td> </tr> </tbody> </table>

Open the first-party source

Technical locator

Archived-source SHA-256: 938a6b525c942df0205c60652b38e52715622fb036622353dc7dae5e29c6f698

The hash identifies the exact response archived at retrieval. The public source is independently reconciled against overlapping SEC evidence where available; it does not replace the SEC fact.